Bacterial physiology: Efflux pumps, fitness and virulence.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Efflux systems driving resistance and virulence across biological domains.PeerJ · 2025
   Review
2. Improving 5-(hydroxymethyl)furfural (HMF) tolerance ofMetabolic engineering communications · 2024
   Article
3. Bacterial resistance to antibacterial agents: Mechanisms, control strategies, and implications for global health.The Science of the total environment · 2023
   Review
4. Efflux-linked accelerated evolution of antibiotic resistance at a population edge.Molecular cell · 2022
   Article
5. Overexpression of RamA, Which Regulates Production of the Multidrug Resistance Efflux Pump AcrAB-TolC, Increases Mutation Rate and Influences Drug Resistance Phenotype.Antimicrobial agents and chemotherapy · 2020
   Article
6. Mechanisms of Bacterial Tolerance and Persistence in the Gastrointestinal and Respiratory Environments.Clinical microbiology reviews · 2018
   Review
7. Interplay Between the Phenotype and Genotype, and Efflux Pumps in Drug-Resistant Strains ofFrontiers in microbiology · 2018
   Article

Corrections and comments

• Comment on
  Lack of AcrB Efflux Function Confers Loss of Virulence on2017
• Comment on
  Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as